KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Change in Account Payables (2016 - 2020)

Historic Change in Account Payables for Thermo Fisher Scientific (TMO) over the last 12 years, with Q4 2020 value amounting to $279.0 million.

  • Thermo Fisher Scientific's Change in Account Payables rose 4234.69% to $279.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $59.0 million, marking a year-over-year decrease of 7781.95%. This contributed to the annual value of $212.0 million for FY2024, which is 14240.0% up from last year.
  • As of Q4 2020, Thermo Fisher Scientific's Change in Account Payables stood at $279.0 million, which was up 4234.69% from $277.0 million recorded in Q3 2020.
  • In the past 5 years, Thermo Fisher Scientific's Change in Account Payables ranged from a high of $279.0 million in Q4 2020 and a low of -$256.0 million during Q2 2020
  • In the last 5 years, Thermo Fisher Scientific's Change in Account Payables had a median value of $15.6 million in 2016 and averaged $42.8 million.
  • Over the last 5 years, Thermo Fisher Scientific's Change in Account Payables had its largest YoY gain of 281287.13% in 2017, and its largest YoY loss of 137450.98% in 2017.
  • Over the past 5 years, Thermo Fisher Scientific's Change in Account Payables (Quarter) stood at -$10.1 million in 2016, then skyrocketed by 2812.87% to $274.0 million in 2017, then dropped by 10.22% to $246.0 million in 2018, then dropped by 20.33% to $196.0 million in 2019, then skyrocketed by 42.35% to $279.0 million in 2020.
  • Its last three reported values are $279.0 million in Q4 2020, $277.0 million for Q3 2020, and -$256.0 million during Q2 2020.